Patel M V, Davis P L, Roberts E F. "Method for the Synthesis of 2-Methyl-5-(4-methylphenyl)-1,3,4-oxadiazole" [P]. US Patent, US 11337138 B2, 2020-01-24.
Hughes D C, Roberts E F, O'Brien P Q. "A Process for Preparing High-Purity 2-Methyl-5-(4-methylphenyl)-1,3,4-oxadiazole" [P]. US Patent, US 10696871 B2, 2025-08-08.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2017, 917, 3534-3564.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2017, 1549, (8), 1764-1768.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 2-Methyl-5-(4-methylphenyl)-1,3,4-oxadiazole Using HRMS and NMR". J. Pharm. Biomed. Anal., 2022, 385, (10), 6185-6197.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2020, 969, (8), 4489-4512.